Marriott International
Recent
price
P/E
ratio
div
yld
0.69%
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Marriott International, Inc. operates as a global lodging company primarily engaged in the ownership, management, and franchising of hotels, residential, and timeshare properties. Its extensive product portfolio includes over 30 distinct brands across various segments such as luxury, premium, extended stay, select service, and outdoor-focused lodging; notable brands include Marriott Hotels & Resorts, The Ritz-Carlton, JW Marriott, St. Regis, The Luxury Collection, W Hotels, Westin, Renaissance, AC Hotels, and Residence Inn. Marriott provides hospitality services including hotel accommodations, residential living, loyalty programs through Marriott Bonvoy, and distinctive guest experiences across nearly 9,600 properties in 143 countries and territories. The company also offers food and beverage services, spa and wellness amenities, meeting and conference facilities, and digital customer engagement platforms. Recent major developments include the acquisition of the lifestyle hotel brand citizenM in 2025, enhancing Marriott’s portfolio with technology-driven, select-service lodging targeted at value-conscious travelers. In 2024, Marriott expanded its non-traditional hospitality offerings through acquisitions and partnerships in the outdoor lodging segment, including Postcard Cabins and a long-term agreement with Trailborn. The company also signed agreements to incorporate iconic properties under its luxury portfolio, such as The Resort at Pelican Hill under St. Regis, The Ritz-Carlton O’ahu Turtle Bay, and several properties within the MGM Collection by Marriott Bonvoy. Marriott reported record signings and openings through 2024 and 2025, with a focused strategic expansion in international markets, especially across EMEA and the APEC region. Operational refinements in 2025 included digital transformation initiatives emphasizing AI and cloud technologies to enhance guest experiences and operational efficiencies. Marriott International operates through multiple business segments categorized by geographic regions including the United States and Canada, Europe, Middle East and Africa (EMEA), Asia Pacific, and Latin America & the Caribbean. It serves diverse customer bases ranging from business and leisure travelers to extended-stay guests and luxury clientele. Founded in 1927 and headquartered in Bethesda, Maryland, Marriott maintains a strong emphasis on innovation, customer loyalty, and global brand diversification, delivering hospitality solutions tailored to a wide range of travel purposes and demographics. Its integrated franchising and management model supports a scalable and flexible global growth strategy, positioning Marriott as a leader in the hotel and lodging industry worldwide.
Company News
Marriott International (MAR) Just Flashed Golden Cross Signal: Do You Buy?
The Marriott Vacation Clubs® and Topeka Collaborate to Launch Moon Crush "Sunshine Live," a New Destination Music Weekend
Will Marriott (MAR) Beat Estimates Again in Its Next Earnings Report?
These 2 Consumer Discretionary Stocks Could Beat Earnings: Why They Should Be on Your Radar
Revisiting Former Stock Picks Marriott, Logitech, Harmony Biosciences
Marriott International, Inc. $MAR Position Lifted by SteelPeak Wealth LLC
3,511 Shares of Marriott International, Inc. $MAR Bought by First Citizens Bank & Trust Co.
Marriott International, Inc. (NASDAQ:MAR) Stock Rated “Moderate Buy” by Sell-Side Analysts
Marriott International Announces Release Date For Third Quarter 2026 Earnings
The Rise of Place: Marriott International Reveals Asia Pacific's Future of Food
THE RITZ-CARLTON NAPLES, TIBURÓN REVEALS TRANSFORMED RESORT AND DYNAMIC CULINARY CONCEPTS
Lisata subsidiary Marea treats first patient in MAR002 acromegaly trial
Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces First Patient Dosed in Phase 2 Clinical Trial of MAR002, a Potential Best-in-disease Investigational Therapy for the Treatment of Acromegaly
Forget Inflation: Funflation Is Here and These ETFs Are Riding on It
Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces Upcoming Late-Breaking Presentation of MAR001 Clinical Data at the American Heart Association Scientific Sessions 2026
Allworth Financial LP Has $5.55 Million Stock Holdings in Marriott International, Inc. $MAR
Marriott International, Inc. (MAR) Presents at Bank of America Gaming and Lodging Conference 2026 Transcript
The Ritz-Carlton Yacht Collection Introduces Its Summer 2028 Mediterranean & Northern Europe Season
California State Teachers Retirement System Has $42.45 Billion Position in Marriott International, Inc. $MAR
Why Is Marriott (MAR) Down 3.1% Since Last Earnings Report?